v3.26.1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

The following tables present revenues and Adjusted EBITDA for each reportable segment for the three and six months ended June 30, 2026 and 2025 (in thousands):

 

 

THREE MONTHS ENDED JUNE 30, 2026

 

 

OUTPATIENT

 

 

PROFESSIONAL

 

 

INTERSEGMENT
ELIMINATIONS

 

 

TOTAL OF
REPORTABLE
SEGMENTS

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Net patient service revenue

 

$

143,747

 

 

$

64,280

 

 

$

(4,292

)

 

$

203,735

 

Management fee and other revenue

 

 

52,462

 

 

 

7,965

 

 

 

 

 

 

60,427

 

Total revenues

 

 

196,209

 

 

 

72,245

 

 

 

(4,292

)

 

 

264,162

 

Other segment items(1)

 

 

149,844

 

 

 

62,165

 

 

 

(4,292

)

 

 

207,717

 

Adjusted EBITDA

 

$

46,365

 

 

$

10,080

 

 

$

 

 

$

56,445

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(10,083

)

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

(3,020

)

Amortization of basis difference

 

 

 

 

 

 

 

 

 

 

 

(573

)

Interest expense

 

 

 

 

 

 

 

 

 

 

 

(16,222

)

Loss on extinguishment and modification of
   debt

 

 

 

 

 

 

 

 

 

 

 

(1,053

)

Gain on disposal of property and equipment

 

 

 

 

 

 

 

 

 

 

 

24

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

(12,737

)

Severance and executive recruiting(2)

 

 

 

 

 

 

 

 

 

 

 

(686

)

Strategic initiatives and implementation(3)

 

 

 

 

 

 

 

 

 

 

 

(2,659

)

Transaction costs(4)

 

 

 

 

 

 

 

 

 

 

 

(707

)

Litigation and settlements(5)

 

 

 

 

 

 

 

 

 

 

 

(1,173

)

Other(6)

 

 

 

 

 

 

 

 

 

 

 

(87

)

Adjustments for equity in earnings of
   unconsolidated affiliates
(7)

 

 

 

 

 

 

 

 

 

 

 

(4,724

)

Net income

 

 

 

 

 

 

 

 

 

 

$

2,745

 

 

 

 

THREE MONTHS ENDED JUNE 30, 2025

 

 

OUTPATIENT

 

 

PROFESSIONAL

 

 

INTERSEGMENT
ELIMINATIONS

 

 

TOTAL OF
REPORTABLE
SEGMENTS

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Net patient service revenue

 

$

138,909

 

 

$

61,400

 

 

$

(2,124

)

 

$

198,185

 

Management fee and other revenue

 

 

48,289

 

 

 

4,928

 

 

 

 

 

 

53,217

 

Total revenues

 

 

187,198

 

 

 

66,328

 

 

 

(2,124

)

 

 

251,402

 

Other segment items(1)

 

 

140,216

 

 

 

57,036

 

 

 

(2,124

)

 

 

195,128

 

Adjusted EBITDA

 

$

46,982

 

 

$

9,292

 

 

$

 

 

 

56,274

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(9,279

)

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

(4,809

)

Amortization of basis difference

 

 

 

 

 

 

 

 

 

 

 

(500

)

Interest expense

 

 

 

 

 

 

 

 

 

 

 

(30,097

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

(8,346

)

Loss on disposal of property and equipment

 

 

 

 

 

 

 

 

 

 

 

(16

)

Severance and executive recruiting(2)

 

 

 

 

 

 

 

 

 

 

 

(803

)

Strategic initiatives and implementation(3)

 

 

 

 

 

 

 

 

 

 

 

(1,018

)

Transaction costs(4)

 

 

 

 

 

 

 

 

 

 

 

(3,875

)

Litigation and settlements(5)

 

 

 

 

 

 

 

 

 

 

 

 

Other(6)

 

 

 

 

 

 

 

 

 

 

 

(142

)

Adjustments for equity in earnings of
   unconsolidated affiliates
(7)

 

 

 

 

 

 

 

 

 

 

 

(4,615

)

Net loss

 

 

 

 

 

 

 

 

 

 

$

(7,226

)

 

 

SIX MONTHS ENDED JUNE 30, 2026

 

 

OUTPATIENT

 

 

PROFESSIONAL

 

 

INTERSEGMENT
ELIMINATIONS

 

 

TOTAL OF
REPORTABLE
SEGMENTS

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Net patient service revenue

 

$

281,839

 

 

$

127,026

 

 

$

(7,812

)

 

$

401,053

 

Management fee and other revenue

 

 

102,269

 

 

 

13,377

 

 

 

 

 

 

115,646

 

Total revenues

 

 

384,108

 

 

 

140,403

 

 

 

(7,812

)

 

 

516,699

 

Other segment items(1)

 

 

299,370

 

 

 

117,497

 

 

 

(7,812

)

 

 

409,055

 

Adjusted EBITDA

 

$

84,738

 

 

$

22,906

 

 

$

 

 

$

107,644

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(20,005

)

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

(4,384

)

Amortization of basis difference

 

 

 

 

 

 

 

 

 

 

 

(1,105

)

Interest expense

 

 

 

 

 

 

 

 

 

 

 

(32,553

)

Loss on extinguishment and modification
   of debt

 

 

 

 

 

 

 

 

 

 

 

(1,053

)

Loss on disposal of property and
   equipment

 

 

 

 

 

 

 

 

 

 

 

(113

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

(25,011

)

Severance and executive recruiting(2)

 

 

 

 

 

 

 

 

 

 

 

(1,631

)

Strategic initiatives and implementation(3)

 

 

 

 

 

 

 

 

 

 

 

(3,484

)

Transaction costs(4)

 

 

 

 

 

 

 

 

 

 

 

(3,289

)

Litigation and settlements(5)

 

 

 

 

 

 

 

 

 

 

 

(1,202

)

Other(6)

 

 

 

 

 

 

 

 

 

 

 

(82

)

Adjustments for equity in earnings of
   unconsolidated affiliates
(7)

 

 

 

 

 

 

 

 

 

 

 

(9,270

)

Net income

 

 

 

 

 

 

 

 

 

 

$

4,462

 

 

 

 

SIX MONTHS ENDED JUNE 30, 2025

 

 

OUTPATIENT

 

 

PROFESSIONAL

 

 

INTERSEGMENT
ELIMINATIONS

 

 

TOTAL OF
REPORTABLE
SEGMENTS

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Net patient service revenue

 

$

272,339

 

 

$

121,954

 

 

$

(3,810

)

 

$

390,483

 

Management fee and other revenue

 

 

95,660

 

 

 

10,260

 

 

 

 

 

 

105,920

 

Total revenues

 

 

367,999

 

 

 

132,214

 

 

 

(3,810

)

 

 

496,403

 

Other segment items(1)

 

 

279,196

 

 

 

113,743

 

 

 

(3,810

)

 

 

389,129

 

Adjusted EBITDA

 

$

88,803

 

 

$

18,471

 

 

$

 

 

 

107,274

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(18,330

)

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

(8,188

)

Amortization of basis difference

 

 

 

 

 

 

 

 

 

 

 

(1,000

)

Interest expense

 

 

 

 

 

 

 

 

 

 

 

(59,946

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

(14,720

)

Gain on disposal of property and
   equipment

 

 

 

 

 

 

 

 

 

 

 

146

 

Severance and executive recruiting(2)

 

 

 

 

 

 

 

 

 

 

 

(2,173

)

Strategic initiatives and implementation(3)

 

 

 

 

 

 

 

 

 

 

 

(1,886

)

Transaction costs(4)

 

 

 

 

 

 

 

 

 

 

 

(7,464

)

Litigation and settlements(5)

 

 

 

 

 

 

 

 

 

 

 

128

 

Other(6)

 

 

 

 

 

 

 

 

 

 

 

(158

)

Adjustments for equity in earnings of
   unconsolidated affiliates
(7)

 

 

 

 

 

 

 

 

 

 

 

(8,596

)

Net loss

 

 

 

 

 

 

 

 

 

 

$

(14,913

)

 

(1)
Other segment items for both segments include certain operating expenses that are not regularly provided to the CODM on a segment basis and that are identifiable with that segment, including general and administrative expenses.
(2)
Includes severance and recruiting expenses for executive leadership departures as part of strategic organizational changes.
(3)
Includes third-party consulting, implementation and integration expenses incurred as part of the Company’s strategic transformation and optimization initiatives, specifically related to the deployment of a new technology system and labor model, as well as the development, customization and integration of a new enterprise resource planning system.
(4)
Includes costs for third-party non-recurring IPO costs, buy-side and sell-side due diligence activities to evaluate and execute potential mergers and acquisitions, integrate acquired businesses and one-time employee retention bonuses related to potential mergers and acquisitions.
(5)
Consists of litigation and settlement costs for matters not related to core operations.
(6)
Consists of other costs related to debt financing, certain de novo start-up costs related to outpatient imaging centers and certain exit costs related to closed outpatient imaging centers.
(7)
Adjusts for the Company’s proportional share of depreciation and amortization, interest expense and losses/gains on asset disposals related to unconsolidated affiliates, which are included in equity in earnings from unconsolidated affiliates on the accompanying condensed consolidated statements of operations and comprehensive income (loss).